文献速递乳腺乳腺X线

现代筛查数字乳腺X线摄影的国家性能基准:乳腺癌监测联盟的更新

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
PubMed 文献 · Radiology · 2016-12-05

该研究基于乳腺癌监测联盟(BCSC)六个登记处、95家机构、359名放射科医师的1 682 504例数字筛查乳腺X线摄影(2007—2013年,792 808名女性),按BI-RADS第5版计算性能指标并建立百分位基准。多数医师达到癌症检出率推荐值,但异常判读率和特异度达标比例较低。

要点

  • 平均异常判读率11.6%,仅59.0%的医师达到推荐范围。
  • 平均癌症检出率5.1/1000例筛查,92.1%的医师达到推荐值。
  • 平均敏感度86.9%,97.1%的医师达到推荐范围。

核心结论

  • BCSC中多数放射科医师的筛查乳腺X线摄影癌症检出率超过推荐值,但近半数医师的异常判读率仍高于推荐率。

研究设计与样本

  • 符合HIPAA、经机构审查委员会批准的研究,测量BCSC六个登记处95家机构359名放射科医师的数字筛查乳腺X线摄影性能,纳入2007—2013年1 682 504例筛查(792 808名女性),按BI-RADS第5版计算指标并与已发表基准比较,基准以医师间性能指标分布的50th(中位数)、10th、25th、75th、90th百分位表示。

诊断标准与关键数值

  • 平均异常判读率11.6%(95%CI:11.5,11.6),癌症检出率5.1/1000例筛查(95%CI:5.0,5.2),敏感度86.9%(95%CI:86.3%,87.6%),特异度88.9%(95%CI:88.8%,88.9%),假阴性率0.8/1000例筛查(95%CI:0.7,0.8),PPV1为4.4%(95%CI:4.3%,4.5%),PPV2为25.6%(95%CI:25.1%,26.1%),PPV3为28.6%(95%CI:28.0%,29.3%),0或1期癌占76.9%,微小癌占57.7%,淋巴结阴性浸润癌占79.4%。

临床应用与阅片要点

  • 92.1%的社区实践放射科医师达到推荐的癌症检出率,97.1%达到推荐敏感度范围,仅59.0%达到推荐异常判读率,仅63.0%达到推荐特异度水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To establish performance benchmarks for modern screening digital mammography and assess performance trends over time in U.S. community practice. Materials and Methods This HIPAA-compliant, institutional review board-approved study measured the performance of digital screening mammography interpreted by 359 radiologists across 95 facilities in six Breast Cancer Surveillance Consortium (BCSC) registries. The study included 1 682 504 digital screening mammograms performed between 2007 and 2013 in 792 808 women. Performance measures were calculated according to the American College of Radiology Breast Imaging Reporting and Data System, 5th edition, and were compared with published benchmarks by the BCSC, the National Mammography Database, and performance recommendations by expert opinion. Benchmarks were derived from the distribution of performance metrics across radiologists and were presented as 50th (median), 10th, 25th, 75th, and 90th percentiles, with graphic presentations using smoothed curves. Results Mean screening performance measures were as follows: abnormal interpretation rate (AIR), 11.6 (95% confidence interval [CI]: 11.5, 11.6); cancers detected per 1000 screens, or cancer detection rate (CDR), 5.1 (95% CI: 5.0, 5.2); sensitivity, 86.9% (95% CI: 86.3%, 87.6%); specificity, 88.9% (95% CI: 88.8%, 88.9%); false-negative rate per 1000 screens, 0.8 (95% CI: 0.7, 0.8); positive predictive value (PPV) 1, 4.4% (95% CI: 4.3%, 4.5%); PPV2, 25.6% (95% CI: 25.1%, 26.1%); PPV3, 28.6% (95% CI: 28.0%, 29.3%); cancers stage 0 or 1, 76.9%; minimal cancers, 57.7%; and node-negative invasive cancers, 79.4%. Recommended CDRs were achieved by 92.1% of radiologists in community practice, and 97.1% achieved recommended ranges for sensitivity. Only 59.0% of radiologists achieved recommended AIRs, and only 63.0% achieved recommended levels of specificity. Conclusion The majority of radiologists in the BCSC surpass cancer detection recommendations for screening mammography; however, AIRs continue to be higher than the recommended rate for almost half of radiologists interpreting screening mammograms. © RSNA, 2016 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lehman CD, Arao RF, Sprague BL, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2016. PMID: 27918707. doi:10.1148/radiol.2016161174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。